vTv Therapeutics Inc (FRA:5VT0) Stock News, Headlines & Updates
vTv Therapeutics Inc Stock News from GuruFocus
- 1
Jun 11, 2025
vTv Therapeutics to Participate in the H.C. Wainwright “HCW@Home” Series
Marketwired • 7:00am
May 19, 2025
vTv Therapeutics (VTVT) Appoints New CFO | VTVT Stock News
GuruFocus News • 8:31am
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin | VTVT Stock News
GuruFocus News • 8:24am
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
Marketwired • 8:00am
May 15, 2025
VTVT Advances Cadisegliatin Program with Phase 3 Study | VTVT Stock News
GuruFocus News • 4:04pm
vTv Therapeutics Announces 2025 First Quarter Financial Results and Provides Corporate Update
Marketwired • 4:00pm
vTv Therapeutics Inc Reports Q1 2025 EPS of -$0.77, Beating Estimates; Net Loss at $5.1 Million
GuruFocus News • 3:34pm
vTv Therapeutics Announces Reinitiation of Screening in CATT1 Phase 3 Trial Evaluating Potential First-in-Class Liver-Selective Glucokinase Activator Cadisegliatin for Type 1 Diabetes | VTVT Stock New
GuruFocus News • 11:16am
vTv Therapeutics (VTVT) Resumes Phase 3 Trial for Diabetes Treatment | VTVT Stock News
GuruFocus News • 11:15am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news